Objective: This study determined the percentage of patients seeking dermatologic treatment who screened positive for BDD.
Methods: A validated self-report questionnaire and a reliable defect severity scale were used to determine the rate of BDD in 268 patients seeking dermatologic treatment.
Results: A total of 11.9 % (95 % confidence interval [CI] , 8.0 % –15.8 % ) of patients screened positive for BDD. Rates were similar in a community general dermatology setting (14.4 % [95 % Cl, 8.5 % –20.3 % ]) and a university cosmetic surgery setting (10.0 % [95 % CI, 6.1 % –13.9 % ]).
Conclusion: BDD appears relatively common among patients seeking dermatologic treatment. Further research is needed to confirm these findings and to assist dermatologists in identifying these potentially high-risk patients.